Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00549341 · ClinicalTrials.gov registry record · Phase 1
PurTox (Botulinum Toxin Type A) for the Treatment of Adult Onset Spasmodic Torticollis/Cervical Dystonia
A Phase 1 study, sponsored by Mentor Worldwide.
- Completed
- Registry status
- Phase 1
- Development phase
- 70
- Enrollment target
NCT00549341 is a Phase 1 study that has completed, run by Mentor Worldwide. The registered enrollment target is 70 participants.
The verdict
NCT00549341, a Phase 1 study, has completed, sponsored by Mentor Worldwide.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 70 participants
- Enrollment target
Study Summary
The safety and efficacy of Mentor Purified Toxin, Botulinum Toxin Type A, Purified Neurotoxin, injected intramuscularly into the neck, is being evaluated as a treatment for painful and non-painful spasmodic torticollis/cervical dystonia. It is hypothesized that treatment will decrease symptom severity and will not have any significant side effects.
Interventions
- DRUG Mentor Purified Toxin, Botulinum Toxn Type A, Purified Neurotoxin
- OTHER Physiologic saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2006-05 |
| Est. Completion | 2009-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00549341
The ClinicalTrials.gov registry entry for NCT00549341 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mentor Worldwide, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mentor Purified Toxin, Botulinum Toxn Type A, Purified Neurotoxin is the first listed.
NCT00549341 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00549341 about?
NCT00549341 is a clinical study titled "PurTox (Botulinum Toxin Type A) for the Treatment of Adult Onset Spasmodic Torticollis/Cervical Dystonia". The safety and efficacy of Mentor Purified Toxin, Botulinum Toxin Type A, Purified Neurotoxin, injected intramuscularly into the neck, is being evaluated as a treatment for painful and non-painful spasmodic torticollis/cervical dystonia. It is hypothesized that treatment will decrease symptom severi...
What is the current status of trial NCT00549341?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 70 participants. The study started on 2006-05. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00549341?
The interventions under investigation include: Mentor Purified Toxin, Botulinum Toxn Type A, Purified Neurotoxin (DRUG), Physiologic saline (OTHER).
Who is sponsoring clinical trial NCT00549341?
This trial is sponsored by Mentor Worldwide, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.